Report
Jeanie Chen
EUR 100.00 For Business Accounts Only

Yakult's overseas strength offset pharma weakness; China growth accelerated

Narrow-moat Yakult got off a good start in fiscal 2018 with a 2.3% growth in sales and flat operating profits. The results are slightly better than our expectation and seems largely in line with the company's guidance. Despite a sizable profit decline in the pharma business, moaty probiotic drinks posted healthy growth in Asia, the key growth driver in our assumptions. Yakult's shares were up more than 6% after the announcement during trading hours. We suspect the preliminary report of an accele...
Underlying
Yakult Honsha Co. Ltd.

Yakult Honsha is a food and beverage manufacturing group. Along with its affiliates, Co. operates in two business segments: beverages and food, and pharmaceutical. The Beverages and Food segment manufactures and sells dairy products, beverages including juices and soft drinks, as well as noodles and health food. Co. is also involved in the transportation of its products and the sale of materials. The Pharmaceuticals segment is engaged in the manufacture and sale of medicines to local hospitals and pharmacies through pharmaceutical wholesalers. In addition, Co. is engaged in the production and sale of cosmetics and the operation of its professional baseball club.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Jeanie Chen

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch